Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Arch. cardiol. Méx ; 92(3): 334-341, jul.-sep. 2022. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1393828

ABSTRACT

Abstract Objective: We evaluated whether cholesteryl ester transfer protein (CETP) gene polymorphisms are associated with the presence of coronary artery disease (CAD) and/or restenosis in patients with coronary stent. Methods: Two polymorphisms of the CETP gene [−971 A/G (rs4783961), and Taq1B A/G (rs708272)] were genotyped by 5'exonuclease TaqMan assays in 219 patients with CAD (66 patients with restenosis and 153 without restenosis) and 607 control individuals. Results: The distribution of polymorphisms was similar in patients with and without restenosis. However, when the whole group of patients (with and without restenosis) was compared to healthy controls, under dominant model, the G allele of the Taq1B A/G polymorphism was associated with increased risk of CAD (odds ratio [OR] = 1.48, pCDom = 0.032). In the same way, under codominant, dominant, and additive models, the A allele of the −971 A/G polymorphisms was associated with an increased risk of developing CAD (OR = 2.03, pCCo-dom = 0.022, OR = 1.83, pCDom = 0.008, and OR = 1.39, pCAdd = 0.011, respectively). In addition, the linkage disequilibrium showed that the "AG" haplotype was associated with increased risk of developing CAD (OR = 1.28, p = 0.03). Conclusion: This study demonstrates that CETP Taq1B A/G and CETP −971 A/G polymorphisms are associated with an increased risk of developing CAD, but no association with restenosis was observed.


Resumen Objetivo: Evaluamos si los polimorfismos del gen CETP están asociados con la presencia de enfermedad arterial coronaria (EAC) y/o restenosis en pacientes con stent coronario. Métodos: En este estudio se genotiparon dos polimorfismos del gen CETP [−971 A/G (rs4783961) y Taq1B A/G (rs708272)] mediante ensayos de 5'exonucleasa TaqMan en 219 pacientes con EAC (66 pacientes con restenosis y 153 sin restenosis), y 607 individuos de control. Resultados: La distribución de polimorfismos fue similar en pacientes con y sin restenosis. Sin embargo, cuando se comparó todo el grupo de pacientes (con y sin restenosis) con controles sanos, bajo el modelo dominante el alelo G del polimorfismo Taq1B A/G se asocia con un mayor riesgo de EAC (OR = 1.48, pCDom = 0.032). De la misma manera, bajo los modelos co-dominante, dominante y aditivo, el alelo A de los polimorfismos −971 A/G se asocia con un mayor riesgo de desarrollar EAC (OR = 2.03, pCCo-dom = 0.022, OR = 1.83, pCDom = 0,008 y OR = 1.39, pCAdd = 0.011, respectivamente). Adicionalmente, el desequilibrio de ligamiento mostró que el haplotipo "AG" se asocia con un mayor riesgo de desarrollar EAC (OR = 1.28, p = 0.03). Conclusión: En resumen, este estudio demuestra que los polimorfismos CETP Taq1B A/G y CETP −971 A/G están asociados con un mayor riesgo de desarrollar CAD, pero no se observó asociación con restenosis.

2.
Rev. invest. clín ; 72(1): 19-24, Jan.-Feb. 2020. tab
Article in English | LILACS | ID: biblio-1251830

ABSTRACT

ABSTRACT Background: Previous studies have shown an association between polymorphisms of the BAT1-NF-κB inhibitor-like-1 (NFKBIL1)-LTA genomic region and susceptibility to myocardial infarction and acute coronary syndrome (ACS). Objective: The objective of the study was to study the role of three polymorphisms in the BAT1, NFKBIL1, and LTA genes on the susceptibility or protection against ACS; we included a group of cases-controls from Central Mexico. Methods: The BAT1 rs2239527C/G, NFKBIL1 rs2071592T/A, and LTA rs1800683G/A polymorphisms were genotyped using a 5' TaqMan assay in a group of 625 patients with ACS and 617 healthy controls. Results: Under a recessive model, the BAT1 -23C/G (rs2239527) polymorphism showed an association with protection against ACS (odds ratio = 0.56, and p-corrected = 0.019). In contrast, the genotype and allele frequencies of the NFKBIL1 rs2071592T/A and LTA rs1800683G/A polymorphisms were similar between ACS patients and controls and no association was identified. Conclusion: Our data suggest an association between the BAT1 -23C/G polymorphism and protection against ACS in Mexican patients.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , DEAD-box RNA Helicases/genetics , Acute Coronary Syndrome/genetics , Myocardial Infarction/genetics , Case-Control Studies , Lymphotoxin-alpha/genetics , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide , Adaptor Proteins, Signal Transducing/genetics , Gene Frequency , Genotype , Mexico
3.
Mem. Inst. Oswaldo Cruz ; 111(12): 757-764, Dec. 2016. graf
Article in English | LILACS | ID: biblio-829258

ABSTRACT

We evaluated the effects of a non-hepatotropic parasite infection (Taenia crassiceps) on the outcome of acetaminophen-induced acute liver failure in mice. Uninfected and T. crassiceps infected mice orally received either 300 mg/kg acetaminophen or water as vehicle (n = 5 per group). Survival analysis, hepatocyte necrosis, alanine aminotransferase (ALT) levels, CYP2E1 protein, interleukin (IL-) 5, and IL-6 were assessed for all groups. All infected mice died within 16 h after exposure to acetaminophen (Tc+APAP group), whereas only one-third of uninfected animals exposed to acetaminophen (APAP group) died. Uninfected (Control group) and infected (Tc group) mice that received the vehicle showed no liver damage. Tc+APAP mice exhibited massive liver necrosis characterised by marked balloning degeneration of hepatocytes and higher serum ALT compared to Control, Tc, and APAP animals. Liver tissue from Tc+APAP mice also displayed increased expression of CYP2E1 protein and higher mRNA and protein levels of IL-5 and IL-6 compared to the other groups. These findings suggest that non-hepatotropic parasite infections may increase mortality following acute liver failure by promoting hepatocyte necrosis via IL-5 and IL-6-dependent CYP2E1 overproduction. This study identifies new potential risk factors associated with severe acute liver failure in patients.


Subject(s)
Animals , Female , Acetaminophen , Analgesics, Non-Narcotic , Liver Failure, Acute , Taeniasis/parasitology , Acetaminophen/administration & dosage , Alanine Transaminase/blood , Analgesics, Non-Narcotic/administration & dosage , Biomarkers/blood , Cytochrome P-450 CYP2E1/biosynthesis , Cytochrome P-450 CYP2E1/blood , Disease Models, Animal , Hepatocytes/parasitology , Hepatocytes/pathology , Interleukin-5/blood , Interleukin-6/blood , Liver Failure, Acute/chemically induced , Liver Failure, Acute/mortality , Liver Failure, Acute/parasitology , Liver Failure, Acute/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Taeniasis/pathology
4.
Rev. cuba. med. gen. integr ; 13(5): 443-7, sept.-oct. 1997.
Article in Spanish | LILACS | ID: lil-223718

ABSTRACT

La escasa bibliografía referida al tema motivó este estudio proponiéndonos aportar material de referencia a residentes de Medicina General Integral para su docencia. Realizamos el trabajo con 71 familiares. Obtuvimos información a partir del modelo de entrevistas eleborado para esos fines el cual explora el reconocimiento del fenómeno más importante que enfrentan y la reacción de toda la familia ante éste. En todos los casos tomamos el dato primario de las madres por ser las que tienen mayor dominio de los que sucede en su grupo social, al menos en nuestro medio. Entre los resultados se reconoce lo fundamental que ocurre en la dinámica familiar, se logra una visión de la tendencia del comportamiento familiar en cada momento de su desarrollo, así como el reporte de vivencias


Subject(s)
Humans , Family Characteristics , Family/psychology , Interviews as Topic , Physicians, Family , Primary Health Care
SELECTION OF CITATIONS
SEARCH DETAIL